We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.50 | 0.28% | 1,599.50 | 1,604.00 | 1,605.00 | 1,612.50 | 1,591.00 | 1,600.50 | 5,248,767 | 16:35:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.40 | 66.06B |
Date | Subject | Author | Discuss |
---|---|---|---|
04/6/2024 10:14 | hxxps://www.drugwatc | s2lowner1 | |
04/6/2024 10:05 | In 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. That is in a single year. Of the 70,000 individuals involved in this litigation, what proportion would have fallen into the above category, anyway? | tradermichael | |
04/6/2024 08:30 | US courts have a history of fleecing non-US companies. Cancer levels are increasing world wide.... Something somewhere is causing it... | netcurtains | |
03/6/2024 22:14 | how come San and PFE were up today if they're all in it together? realise that PFE announced a good result for two of their drugs at ASCO, adcetris and an ALCL drug but GSK also came out with good reports on Blenrep and Jemperli particularly the latter : may be GSK would have much larger exposure than the other 2 should the litigation succeed? | c3479z | |
03/6/2024 19:37 | Should bounce 20p to 40p tomorrow but worrying times long term with these lawsuits. | con90210 | |
03/6/2024 19:31 | CynicalSteve "One of the reasons why America is so wealthy " haha America is bust. National Debt is $34trillion and rising. Unsustainable. Wealthy? It's founded on a debt financed illusion. Bit like UK in fact. And Japan, and Europe, and most of the world! | geckotheglorious | |
03/6/2024 17:39 | One of the reasons why America is so wealthy is that they steal money from foreign investors (especially us) at every opportunity. | cynicalsteve | |
03/6/2024 16:55 | I've topped up too based on the Yield for the Long Term. Not overly convinced I shouldn't have waited a little longer though......... | jason29 | |
03/6/2024 16:28 | Topped up, 2 other good RNSs released | dewalt | |
03/6/2024 14:56 | Alcohol is the main dietary risk factor in oesophageal cancer and I would guess stomach cancer - followed by smoking. Diet has a significant impact on colon and bowel cancer, lack of fibre in the modern diet, etc. Some people unfortunately just get unlucky, regardless of lifestyle. | essentialinvestor | |
03/6/2024 14:17 | I think 1660-1675p close today in auction. | ghost_walker | |
03/6/2024 13:02 | Silly fall. Incomprehensible really. I'll buy more. | pander45 | |
03/6/2024 12:45 | You're right. I'm going to panic and sell like all the other muppets this morning.. despite there being absolutely nothing in this. That judge should know better. | rikky72 | |
03/6/2024 12:23 | How many of those 70,000 have consumed large amounts of these substances that are linked to cancer: Tobacco. Red meats. Red meat such as beef, pork, venison and lamb has been linked to colorectal cancer ... Processed meats. Another category of meat that comes with a heightened cancer risk is processed meat. ... Alcohol. ... Ultra-processed food and drinks. ... Food and drinks with added sugar. A small amount of Zantac that has been shown to be stable from breakdown to MDNA (unless exposed to very high temperatures) when consumed with the above cannot be proven to be solely responsible for cancer in the thousands of Americans concerned. | tradermichael | |
03/6/2024 12:22 | I'm sure if an American company no problem, but U.K. based who knows. | montyhedge | |
03/6/2024 12:09 | 24.06.2024 - GSK plc (LSE/NYSE: GSK) welcomes todays jury verdict in the Valadez case in Illinois state court finding in GSK's favour in the first Zantac case to go to trial. This outcome is consistent with the scientific consensus that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer, supported by 16 epidemiological studies looking at human data regarding the use of ranitidine. GSK will continue to vigorously defend itself against all other claims. Prior to this verdict, the court rejected the plaintiffs ability to request punitive damages.. | laurence llewelyn binliner | |
03/6/2024 11:53 | Such a big case will divert senior management time for some time to come. It may be beneficial for GSK (and others) to set up a separate foundation to deal with this issue. | alphorn | |
03/6/2024 11:48 | I'm in 16.01 | panache1 | |
03/6/2024 11:24 | that is no more likely than it was on Friday | melody9999 | |
03/6/2024 11:22 | 70,000 victims. 1m compensation each (that is small in America). £70bn hit. Could this company go bankrupt? | mortal1ty |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions